Editas Medicine, Inc. (EDIT) is gaining attention as a potential top biotech penny stock to consider buying. With its innovative technology and promising developments in gene editing, Editas Medicine has the potential for significant growth in the biotech sector. Investors are keeping a close eye on this company as it continues to make strides in the field of genetic medicine. If you are looking for a biotech penny stock with potential, Editas Medicine, Inc. may be worth considering.